We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.

Delisted

AMPE was delisted on the 12th of April, 2024.

80 hedge funds and large institutions have $47M invested in Ampio Pharmaceuticals Inc. in 2014 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 32 increasing their positions, 13 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

146% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 13

67% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 9

7% more funds holding

Funds holding: 7580 (+5)

53% less call options, than puts

Call options by funds: $853K | Put options by funds: $1.82M

60% less capital invested

Capital invested by funds: $116M → $47M (-$69.1M)

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
80
Holders Change
+5
Holders Change %
+6.67%
% of All Funds
2.32%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
15
Increased
32
Reduced
13
Closed
9
Calls
$853K
Puts
$1.82M
Net Calls
-$967K
Net Calls Change
+$1.3M
Name Holding Trade Value Shares
Change
Change in
Stake
SGH
26
Schonfeld Group Holdings
New York
$286K +$455K +270 New
CP
27
Camelot Portfolios
Ohio
$272K +$121K +72 +39%
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$265K +$1.68K +1 +0.4%
AIG
29
American International Group
New York
$226K +$55.6K +33 +18%
Charles Schwab
30
Charles Schwab
California
$206K
TA
31
Teachers Advisors
New York
$197K
SIP
32
Stoneridge Investment Partners
Pennsylvania
$188K +$298K +177 New
GIA
33
GHP Investment Advisors
Colorado
$177K
PAAMCP
34
Pacific Alternative Asset Management Company (PAAMCO)
California
$140K +$222K +132 New
AllianceBernstein
35
AllianceBernstein
Tennessee
$115K -$43.8K -26 -19%
NFA
36
Nationwide Fund Advisors
Ohio
$112K +$1.68K +1 +1%
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$111K +$1.68K +1 +1%
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
$106K +$30.3K +18 +22%
VOYA Investment Management
39
VOYA Investment Management
Georgia
$99K
TC
40
TFS Capital
Pennsylvania
$98K +$155K +92 New
Bank of America
41
Bank of America
North Carolina
$94K +$140K +83 +1,660%
Verition Fund Management
42
Verition Fund Management
Connecticut
$94K +$150K +89 New
BA
43
BlackRock Advisors
Delaware
$93K
FIM
44
Frontier Investment Management
Texas
$88K +$140K +83 New
HCM
45
Highbridge Capital Management
New York
$83K +$133K +79 New
Bank of Montreal
46
Bank of Montreal
Ontario, Canada
$74K +$113K +67 +2,233%
California Public Employees Retirement System
47
California Public Employees Retirement System
California
$72K
State Board of Administration of Florida Retirement System
48
State Board of Administration of Florida Retirement System
Florida
$69K
WIC
49
Wood Investment Counsel
Colorado
$69K
Brown Advisory
50
Brown Advisory
Maryland
$59K +$94.3K +56 New

AMPE Hedge Fund Activity: Q3 2014 in Review

80 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q3 2014, worth a combined $47M — down 60% from $116M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new AMPE positions and 9 closed out — a net gain of 6 holders — while 32 added to existing stakes and 13 trimmed.

The largest buyer was Knoll Capital Management, adding an estimated $2.28M. The largest seller was DAFNA Capital Management, cutting an estimated $7.02M.

  • 80 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q3 2014, up from 75 in Q2 2014.
  • Funds reported $47M of Ampio Pharmaceuticals Inc. stock for Q3 2014, down 60% quarter-over-quarter.
  • 15 funds opened new Ampio Pharmaceuticals Inc. positions in Q3 2014 and 9 closed out, a net change of +6 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q3 2014 was Knoll Capital Management, an estimated $2.28M added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q3 2014 was DAFNA Capital Management, an estimated $7.02M sold.

Based on aggregated 13F filings for Q3 2014.